Dr. Jan Lichtenberg

InSphero

3D cell culture and the innovations driving the next frontier in drug discovery

Dr. Jan Lichtenburg explains how InSphero, an expert in 3D cell culture, is helping pharmaceutical companies and Biotech’s to carry out more predictive cell-based assays. He looks back at the innovations that have shaped the field of drug discovery and the technology that helps drive InSpero’s mission to replace animal testing with 3D in vitro models. Finally, he describes what he hopes to see for the future of drug discovery.



LIKE 0
Dr. Jan Lichtenberg
Cell Culture SLAS2023

Dr. Jan Lichtenberg

Biography

Dr. Jan Lichtenberg, Chief Executive Officer and Co-Founder, InSphero More

Dr. Jan Lichtenberg

InSphero

Dr. Jan Lichtenberg is the Co-Founder and CEO of InSphero., a global leader in 3D cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. Lichtenberg holds a Master of Science in Microtechnology from the University of Bremen, and a Master's degree in Microelectronics from EPFL. He earned his Ph.D. in Microtechnology and Microfluidics at Université de Neuchâtel. With over a decade of experience and expertise, Dr. Lichtenberg has guided InSphero to provide advanced in vitro models, offering precise alternatives to animal testing, and providing more accurate physiological models.